INTRODUCTION: We assessed the long-term follow-up examinations and complications of percutaneous transluminal angioplasty and stenting (PTAS) for symptomatic ostial vertebral artery (VA) stenosis. METHODS: A retrospective study was done to evaluate 12 patients with symptomatic ostial VA stenosis who underwent PTAS. Six patients were treated with the Palmaz stent and six with a balloon-expandable coronary stent. Initial angiographic follow-up examination was conducted about 12 months after PTAS in all patients. Simple radiographic, ultrasonographic and clinical follow-up examinations were scheduled every 6 months. RESULTS: Excellent dilatation was achieved in all patients without any procedural complications. Initial angiographic follow-up obtained at a mean of 13 months after PTAS detected no restenosis. However, an asymptomatic severe restenosis was detected at 24 months after PTAS in one patient (8%). During a mean follow-up of 31.5 months, three stent fractures were detected in deployed coronary stents (50%). None of the stent fractures was associated with either recurrent stroke or restenosis. No patients developed recurrent symptoms during the follow-up period. CONCLUSION: PTAS for symptomatic ostial VA stenosis is effective in preventing recurrent stroke. As the open-cell single-joint type of stent is associated with the risk of fracture, long-term follow-up examinations including simple radiography are needed.
INTRODUCTION: We assessed the long-term follow-up examinations and complications of percutaneous transluminal angioplasty and stenting (PTAS) for symptomatic ostial vertebral artery (VA) stenosis. METHODS: A retrospective study was done to evaluate 12 patients with symptomatic ostial VA stenosis who underwent PTAS. Six patients were treated with the Palmaz stent and six with a balloon-expandable coronary stent. Initial angiographic follow-up examination was conducted about 12 months after PTAS in all patients. Simple radiographic, ultrasonographic and clinical follow-up examinations were scheduled every 6 months. RESULTS: Excellent dilatation was achieved in all patients without any procedural complications. Initial angiographic follow-up obtained at a mean of 13 months after PTAS detected no restenosis. However, an asymptomatic severe restenosis was detected at 24 months after PTAS in one patient (8%). During a mean follow-up of 31.5 months, three stent fractures were detected in deployed coronary stents (50%). None of the stent fractures was associated with either recurrent stroke or restenosis. No patients developed recurrent symptoms during the follow-up period. CONCLUSION: PTAS for symptomatic ostial VA stenosis is effective in preventing recurrent stroke. As the open-cell single-joint type of stent is associated with the risk of fracture, long-term follow-up examinations including simple radiography are needed.
Authors: M Sakaguchi; K Kitagawa; H Hougaku; H Hashimoto; Y Nagai; H Yamagami; T Ohtsuki; N Oku; K Hashikawa; K Matsushita; M Matsumoto; M Hori Journal: Neurology Date: 2003-09-23 Impact factor: 9.910
Authors: Deepak L Bhatt; Michel E Bertrand; Peter B Berger; Philippe L L'Allier; Issam Moussa; Jeffrey W Moses; George Dangas; Megumi Taniuchi; John M Lasala; David R Holmes; Stephen G Ellis; Eric J Topol Journal: J Am Coll Cardiol Date: 2002-01-02 Impact factor: 24.094
Authors: Felipe C Albuquerque; David Fiorella; Patrick Han; Robert F Spetzler; Cameron G McDougall Journal: Neurosurgery Date: 2003-09 Impact factor: 4.654
Authors: H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw Journal: N Engl J Med Date: 1991-08-15 Impact factor: 91.245
Authors: Christian Mueller; Helmut Roskamm; Franz-Josef Neumann; Patrick Hunziker; Stephan Marsch; André Perruchoud; Heinz J Buettner Journal: J Am Coll Cardiol Date: 2003-03-19 Impact factor: 24.094
Authors: Sun Young Chung; Deok Hee Lee; Jin Woo Choi; Byung Se Choi; Hyun Sin In; Sun Mi Kim; Choong Gon Choi; Sang Joon Kim; Dae Chul Suh Journal: Korean J Radiol Date: 2010-02-22 Impact factor: 3.500
Authors: Nso Nso; Mahmoud Nassar; Mia Trimingham; Yolanda Mbome; Anthony Lyonga Ngonge; Solomon O Badejoko; Shahzad Akbar; Atika Azhar; Sofia Lakhdar; Muhammad Ghallab; Laura M Guzman Perez; Vincent Rizzo; Most Sirajum Munira Journal: Cureus Date: 2022-05-05
Authors: Man Kwun Andrew Li; Anderson Chun On Tsang; Frederick Chun Pong Tsang; Wai Shing Ho; Raymand Lee; Gilberto Ka Kit Leung; Wai Man Lui Journal: Clin Neuroradiol Date: 2018-07-23 Impact factor: 3.649
Authors: Z Vajda; E Miloslavski; T Güthe; S Fischer; G Albes; A Heuschmid; H Henkes Journal: AJNR Am J Neuroradiol Date: 2009-09-03 Impact factor: 3.825